Reata Pharmaceuticals Price on July 6, 2023
RETADelisted Stock | USD 109.67 3.31 2.93% |
If you're considering investing in Reata Stock, it is important to understand the factors that can impact its price. As of today, the current price of Reata Pharmaceuticals stands at 109.67, as last reported on the 29th of November, with the highest price reaching 115.23 and the lowest price hitting 109.66 during the day. We have found twenty-nine technical indicators for Reata Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Reata Pharmaceuticals' Risk Adjusted Performance of 0.0484, semi deviation of 3.31, and Coefficient Of Variation of 1897.93 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Reata Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Reata |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
RETA |
Based on monthly moving average Reata Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Reata Pharmaceuticals by adding Reata Pharmaceuticals to a well-diversified portfolio.
Reata Pharmaceuticals Main Headline on 6th of July 2023
TD Cowen starts Reata at outperform, cites sales potential o... by seekingalpha.com
TD Cowen initiated coverage of Reata with an outperform rating, citing the revenue potential of the companys recently approved drug Skyclarys for Friedrichs ataxia.
Reata Pharmaceuticals Valuation on July 6, 2023
It is possible to determine the worth of Reata Pharmaceuticals on a given historical date. On July 6, 2023 Reata was worth 104.8 at the beginning of the trading date compared to the closed value of 107.89. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Reata Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Reata Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Reata Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Reata Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
102.88 | 104.58 | 102.27 | 103.90 | 347,677 | |
07/06/2023 | 104.80 | 108.00 | 103.18 | 107.89 | 683,653 |
108.00 | 108.50 | 103.78 | 104.37 | 627,871 |
Backtest Reata Pharmaceuticals | | | Reata Pharmaceuticals History | | | Reata Pharmaceuticals Valuation | Previous | Next |
Reata Pharmaceuticals Trading Date Momentum on July 6, 2023
On July 07 2023 Reata Pharmaceuticals was traded for 104.37 at the closing time. The top price for the day was 108.50 and the lowest listed price was 103.78 . The trading volume for the day was 627.9 K. The trading history from July 7, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.26% . The trading delta at closing time against the current closing price is 1.40% . |
Reata Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Reata Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Reata Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Reata financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Reata Pharmaceuticals Stock history
Reata Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Reata is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Reata Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Reata Pharmaceuticals stock prices may prove useful in developing a viable investing in Reata Pharmaceuticals
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. Reata Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Plano, Texas. Reata Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 346 people.
Reata Pharmaceuticals Stock Technical Analysis
Reata Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Reata Pharmaceuticals Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Reata Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Reata Pharmaceuticals November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Reata Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reata Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Reata Pharmaceuticals stock market strength indicators, traders can identify Reata Pharmaceuticals entry and exit signals to maximize returns
Reata Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Reata Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Reata Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Reata to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0484 | |||
Jensen Alpha | 0.1074 | |||
Total Risk Alpha | (0.39) | |||
Sortino Ratio | 0.0225 | |||
Treynor Ratio | 0.2559 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Reata Stock
If you are still planning to invest in Reata Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reata Pharmaceuticals' history and understand the potential risks before investing.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |